These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29246035)

  • 1. Enhancing cell and gene therapy manufacture through the application of advanced fluorescent optical sensors (Review).
    Harrison RP; Chauhan VM
    Biointerphases; 2017 Dec; 13(1):01A301. PubMed ID: 29246035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing.
    Esmonde-White KA; Cuellar M; Uerpmann C; Lenain B; Lewis IR
    Anal Bioanal Chem; 2017 Jan; 409(3):637-649. PubMed ID: 27491299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centralised versus decentralised manufacturing and the delivery of healthcare products: A United Kingdom exemplar.
    Harrison RP; Rafiq QA; Medcalf N
    Cytotherapy; 2018 Jun; 20(6):873-890. PubMed ID: 29807726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decentralized manufacturing of cell and gene therapies: Overcoming challenges and identifying opportunities.
    Harrison RP; Ruck S; Medcalf N; Rafiq QA
    Cytotherapy; 2017 Oct; 19(10):1140-1151. PubMed ID: 28797612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good manufacturing practice production of adenoviral vectors for clinical trials.
    Lusky M
    Hum Gene Ther; 2005 Mar; 16(3):281-91. PubMed ID: 15812223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate data analysis in cell gene therapy manufacturing.
    Emerson J; Kara B; Glassey J
    Biotechnol Adv; 2020 Dec; 45():107637. PubMed ID: 32980438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop.
    Ball O; Robinson S; Bure K; Brindley DA; Mccall D
    Cytotherapy; 2018 Apr; 20(4):592-599. PubMed ID: 29452894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality cell therapy manufacturing by design.
    Lipsitz YY; Timmins NE; Zandstra PW
    Nat Biotechnol; 2016 Apr; 34(4):393-400. PubMed ID: 27054995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-use disposable technologies for biopharmaceutical manufacturing.
    Shukla AA; Gottschalk U
    Trends Biotechnol; 2013 Mar; 31(3):147-54. PubMed ID: 23178074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese medicine industry 4.0：advancing digital pharmaceutical manufacture toward intelligent pharmaceutical manufacture].
    Cheng YY; Qu HB; Zhang BL
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(1):1-5. PubMed ID: 28845630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decentralised manufacturing of cell and gene therapy products: Learning from other healthcare sectors.
    Harrison RP; Ruck S; Rafiq QA; Medcalf N
    Biotechnol Adv; 2018; 36(2):345-357. PubMed ID: 29278756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manufacturing of biodrugs: need for harmonization in regulatory standards.
    Sahoo N; Choudhury K; Manchikanti P
    BioDrugs; 2009; 23(4):217-29. PubMed ID: 19697964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies.
    Myles L; Church TD
    Cytotherapy; 2022 Mar; 24(3):344-355. PubMed ID: 34750073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell, tissue and gene products with marketing authorization in 2018 worldwide.
    Cuende N; Rasko JEJ; Koh MBC; Dominici M; Ikonomou L
    Cytotherapy; 2018 Nov; 20(11):1401-1413. PubMed ID: 30366616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-processing strategies for biologicals API manufacturing processes.
    Opitz U
    Dev Biol (Basel); 2003; 113():101-4; discussion 115-6. PubMed ID: 14620858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?
    Chen LN; Collins-Johnson N; Sapp N; Pickett A; West K; Stroncek DF; Panch SR
    Transfusion; 2019 Aug; 59(8):2506-2518. PubMed ID: 31135995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.